Effects of angiotensin blockade on the splanchnic circulation in normotensive humans.
The effects of angiotensin-converting enzyme inhibition (ACE-I) by enalapril on splanchnic (n = 10) and central hemodynamics (n = 9) were examined in moderately salt-depleted healthy volunteers, at rest and during 15-20 min of lower body negative pressure (LBNP), reducing mean arterial pressure by 10 mmHg. During LBNP before ACE-I, both splanchnic and total peripheral vascular resistances increased. During ACE-I, splanchnic and total peripheral vascular resistances decreased. After enalapril administration, splanchnic vascular resistance did not increase during LBNP. Total peripheral vascular resistance still increased but not to the same extent as during LBNP before ACE-I. The increases in heart rate and plasma norepinephrine during LBNP were attenuated after ACE-I compared with LBNP before ACE-I. The effectiveness of the ACE-I was clearly demonstrated by unchanged and low plasma angiotensin II levels during ACE-I. We conclude that, in normal sodium-depleted humans, acute ACE-I decreases splanchnic vascular resistance at rest and abolishes splanchnic vasoconstriction during LBNP. Furthermore, it may interfere with autonomic nervous system control of the circulation.
Stadeager
C
C
Department of Clinical Physiology, Hvidovre Hospital, Copenhagen, Denmark.
Hesse
B
B
Henriksen
O
O
Christensen
N J
NJ
Bonde-Petersen
F
F
Mehlsen
J
J
Giese
J
J
D000328:Adult; D000803:Angiotensin I / Q000037:antagonists & inhibitors / Q000097:blood / Q000502:physiology*; D000804:Angiotensin II / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure; D002302:Cardiac Output; D004656:Enalapril / Q000494:pharmacology*; D004837:Epinephrine / Q000097:blood; D005260:Female; D006112:Gravitation; D006339:Heart Rate; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000097:blood; D013152:Splanchnic Circulation / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D004656:Enalapril; D000803:Angiotensin I; D009638:Norepinephrine; D004837:Epinephrine